Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy

Impact of a clinical decision support tool on dementia diagnostics in memory clinics: The PredictND validation study

(2019) Marie Bruun et al.   Current Alzheimer Research

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Amsterdam Dementia Cohort: Performing Research to Optimize Care

(2018) Wiesje M. van der Flier et al.   JOURNAL OF ALZHEIMERS DISEASE

Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier

(2018) Antti Tolonen et al.   Frontiers in Aging Neuroscience

A Disease State Fingerprint for Evaluation of Alzheimer's Disease

(2018) Jussi Mattila et al.   JOURNAL OF ALZHEIMERS DISEASE

Optimizing Patient Care and Research: The Amsterdam Dementia Cohort

(2018) Wiesje M. van der Flier et al.   JOURNAL OF ALZHEIMERS DISEASE

Concordance Between Cerebrospinal Fluid Biomarkers and [11C]PIB PET in a Memory Clinic Cohort

(2018) Marissa Zwan et al.   JOURNAL OF ALZHEIMERS DISEASE

Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease

(2018) Leslie M. Shaw et al.   Alzheimers & Dementia

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms

(2018) Sebastian Palmqvist et al.   Alzheimers & Dementia

Clinical Decision Support in the Era of Artificial Intelligence

(2018) Edward H. Shortliffe et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

(2017) Giovanni B Frisoni et al.   LANCET NEUROLOGY

Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

(2017) Niklas Mattsson et al.   NEUROBIOLOGY OF AGING

Communicating mild cognitive impairment diagnoses with and without amyloid imaging

(2017) Joshua D. Grill et al.   Alzheimers Research & Therapy

Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer’s Biomarkers in Daily Practice (ABIDE) Project

(2017) Ingrid S. van Maurik et al.   JAMA Neurology

2016 Alzheimer's disease facts and figures

(2016)   Alzheimers & Dementia

Differential diagnosis of neurodegenerative diseases using structural MRI data

(2016) Juha Koikkalainen et al.   NeuroImage-Clinical

Shared decision making: Concepts, evidence, and practice

(2015) A.M. Stiggelbout et al.   PATIENT EDUCATION AND COUNSELING

Variability of CSF Alzheimer’s Disease Biomarkers: Implications for Clinical Practice

(2014) Stephanie J. B. Vos et al.   PLoS One

Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers

(2013) Xiao Da et al.   NeuroImage-Clinical

Multi-stage segmentation of white matter hyperintensity, cortical and lacunar infarcts

(2012) Yanbo Wang et al.   NEUROIMAGE

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

Fast and robust multi-atlas segmentation of brain magnetic resonance images

(2009) Jyrki MP. Lötjönen et al.   NEUROIMAGE